Zhongbo Han et al.'s research found that microRNA-19b can target NR3C1 for downregulation, inhibiting cell apoptosis through the PI3K/AKT/mTOR pathway, thereby enhancing the resistance of colorectal cancer patients to oxaliplatin (Han et al., 2021). Here, MTOR is linked to colorectal cancer.